Stock listing
Mabion Sa
Selected listing: A1J13Q · LS · EUR · DE
Mabion Sa (Lang & Schwarz: A1J13Q), Health Technology. Latest release Aug 26, 2026: Oddifact and Mabion Receive FDA Pre-IND Meeting Grant for RTX-NP…
- Ticker
- Lang & Schwarz: A1J13Q
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- Lang & Schwarz
- Currency
- EUR
Latest news from Mabion Sa
Oddifact and Mabion Receive FDA Pre-IND Meeting Grant for RTX-NP (MabionCD20) in Immune Thrombocytopenia
August 26, 2026
Mabion S A : Other information to the quarterly report of Mabion S.A. for Q1 2026
May 19, 2026
Mabion S A : Interim condensed financial statements for the 3-month period ended 31 March 2026
May 19, 2026
Mabion S A : Financial statements for the financial year ended 31 December 2025
April 29, 2026
Mabion S A : Presentation of financial results for FY 2025 – Mabion
April 28, 2026
Research Mabion Sa
Alternate listings
MAB:GPW
PL · PLN
Alternate listing for Mabion Sa; the primary context on this page is A1J13Q:LS.
272:GETTEX
DE · EUR
Alternate listing for Mabion Sa; the primary context on this page is A1J13Q:LS.
0QGW:LSE
GB · PLN
Alternate listing for Mabion Sa; the primary context on this page is A1J13Q:LS.
A1J13Q:LSX
DE · EUR
Alternate listing for Mabion Sa; the primary context on this page is A1J13Q:LS.
272:SWB
DE · EUR
Alternate listing for Mabion Sa; the primary context on this page is A1J13Q:LS.
272:FWB
DE · EUR
Alternate listing for Mabion Sa; the primary context on this page is A1J13Q:LS.
272:MUN
DE · EUR
Alternate listing for Mabion Sa; the primary context on this page is A1J13Q:LS.